At the 61st annual European Association for the Study of Diabetes Conference (EASD) this week in Vienna, Austria, glucose monitoring company Dexcom introduced its new offering, the Dexcom Smart Basal, ...

DexCom, Inc. (NASDAQ:DXCM) is one of the best strong buy growth stocks to buy now. On August 21, Argus initiated coverage of DexCom, Inc. (NASDAQ:DXCM) with a Buy rating and $100 price target. Why ...

Insulet’s chief growth officer said: “colour has the power to differentiate a brand,” with mango orange adorning Omnipod’s ...

XPENG is another new fully electric manufacturer to start selling vehicles here. And as you may have guessed by the name, Xpeng is another Chinese car company, and the G6 SUV is its first model to be ...

This video provides an overview of the charging port location and design on the Xpeng G6, highlighting its seamless integration into the vehicle’s bodywork. The segment demonstrates how the flap opens ...

DexCom's returns over the past decade have been solid, but not quite on par with the market's. The company has encountered some headwinds in recent years that have sunk its stock price. Despite the ...

Dexcom (Nasdaq:DXCM) today announced plans to unveil its Smart Basal integrated titration module for insulin delivery.

Hypertension notifications are a new feature in watchOS that comes to several older Apple Watch models, here’s how to set it ...

Don’t have the latest A.I.-powered model? There are still plenty of new features in Apple’s iOS 26 and Google’s Android 16 to ...

Passkeys offer a way of confirming you are who you say you are without remembering a long, complicated password, and in a manner that's resistant to common attacks on passwords like phishing and ...

Two major diabetes tech companies, Dexcom and Insulet, are making changes to their C-suites.  | The changes at the diabetes tech companies include Dexcom announcing that outgoing CEO Kevin Sayer is ...

Investing.com - Oppenheimer downgraded DexCom (NASDAQ:DXCM) stock rating from Outperform to Perform on Monday, citing multiple challenges facing the continuous glucose monitoring device maker.